STOCK TITAN

Tandem Diabetes (TNDM) COO logs RSU vesting, tax withholding and ESPP purchase

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tandem Diabetes Care EVP & COO Jean-Claude Kyrillos reported routine equity compensation activity involving restricted stock units (RSUs), tax withholding, and an employee stock purchase. On May 15, 2026, 4,038 RSUs converted into common stock and 2,139 shares were withheld to cover taxes, with no shares sold. He also acquired 434 shares through the company’s employee stock purchase plan. Following these transactions, he directly holds 27,671 shares of Tandem Diabetes Care common stock.

Positive

  • None.

Negative

  • None.
Insider Kyrillos Jean-Claude
Role EVP & Chief Operating Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 4,038 $0.00 --
Exercise Common Stock 4,038 $0.00 --
Tax Withholding Common Stock 2,139 $12.82 $27K
Grant/Award Common Stock 434 $10.90 $5K
Holdings After Transaction: Restricted Stock Unit — 8,077 shares (Direct, null); Common Stock — 29,810 shares (Direct, null)
Footnotes (1)
  1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c). Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
RSUs converted 4,038 shares Restricted Stock Units converting into common stock on May 15, 2026
Tax-withheld shares 2,139 shares Shares withheld to satisfy tax obligations on RSU vesting
ESPP acquisition 434 shares at $10.90 Common shares acquired via employee stock purchase plan
Shares held after 27,671 shares Direct common stock holdings following all reported transactions
Restricted Stock Unit financial
"Shares withheld by Tandem Diabetes Care Inc. ... on vesting of restricted stock units (RSU)."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Purchase Plan financial
"acquisition of shares of common stock pursuant to the ... Employee Stock Purchase Plan (ESPP)"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(c) regulatory
"This transaction is also exempt under Rule 16b-3(c)."
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
Long-Term Incentive Plan financial
"Awarded ... pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
tax withholding requirements financial
"Shares withheld by Tandem Diabetes Care Inc. ... to satisfy tax withholding requirements"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kyrillos Jean-Claude

(Last)(First)(Middle)
12400 HIGH BLUFF DRIVE

(Street)
SAN DIEGO CALIFORNIA 92130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TANDEM DIABETES CARE INC [ TNDM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M4,038A$029,810D
Common Stock05/15/2026F(1)2,139D$12.8227,671D
Common Stock05/15/2026A(2)434A$10.928,105D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(3)(4)05/15/2026M4,038 (5) (5)Common Stock4,038$08,077D
Explanation of Responses:
1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
2. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c).
3. Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
4. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
5. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Remarks:
/s/ Shannon M. Hansen, Attorney-in-Fact for Jean-Claude Kyrillos05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Tandem Diabetes Care (TNDM) report for Jean-Claude Kyrillos?

Jean-Claude Kyrillos reported RSU vesting, tax withholding, and an employee stock purchase. 4,038 RSUs converted into common shares, 2,139 shares were withheld for taxes, and 434 shares were acquired through the employee stock purchase plan, all on May 15, 2026.

Did the Tandem Diabetes Care (TNDM) executive sell any shares in this Form 4?

No, the filing states no shares were sold. 2,139 shares were withheld by Tandem Diabetes Care to satisfy tax obligations on RSU vesting, which is a non-market disposition, while the remaining vested shares and ESPP shares increased his direct holdings.

How many Tandem Diabetes Care (TNDM) shares does Jean-Claude Kyrillos hold after these transactions?

After the reported transactions, Jean-Claude Kyrillos directly holds 27,671 shares of Tandem Diabetes Care common stock. This figure reflects RSU conversion, tax-withholding share reductions, and the additional 434 shares acquired through the company’s employee stock purchase plan on May 15, 2026.

What RSU activity was disclosed for Tandem Diabetes Care (TNDM) in this Form 4?

The filing shows 4,038 restricted stock units converted into common stock on May 15, 2026. These RSUs were granted under Tandem Diabetes Care’s 2023 Long-Term Incentive Plan and vest one-third initially, with the remaining shares vesting in eight equal quarterly installments thereafter.

What is the role of tax withholding in the Tandem Diabetes Care (TNDM) Form 4?

2,139 shares were withheld by Tandem Diabetes Care to cover tax liabilities arising from RSU vesting. The footnote clarifies this tax-withholding disposition involved no open-market sale, meaning the shares were retained by the company solely to satisfy the executive’s tax obligations.

How were employee stock purchase plan shares reported for Tandem Diabetes Care (TNDM)?

The Form 4 voluntarily reports that Jean-Claude Kyrillos acquired 434 common shares through Tandem Diabetes Care’s Amended and Restated 2013 Employee Stock Purchase Plan. These shares relate to an ESPP purchase period running from November 18, 2025 through May 15, 2026 and are exempt under Rule 16b-3(c).